Issued Patents All Time
Showing 26–50 of 58 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10525056 | Procaspase-activating compounds and methods | — | 2020-01-07 |
| 10350207 | PAC-1 combination therapy | Jessie Peh | 2019-07-16 |
| 10285986 | Compounds and anti-tumor NQO1 substrates | David Boothman, Joseph S. Bair, Rahul Palchaudhuri, Elizabeth I. Parkinson | 2019-05-14 |
| 10272099 | Tumor-selective combination therapy | David Boothman, Joseph S. Bair, Lifen Cao, Jinming Gao, Xiumei HUANG +4 more | 2019-04-30 |
| 10220099 | Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]indole-1,4-diones for cancer treatment | Mohammad Movassaghi, Justin Kim, Karen Morrison, Nicolas Cedric Boyer | 2019-03-05 |
| 10166229 | Compounds and methods for the treatment of cancer | Karson S. Putt, Quinn P. Peterson, Valerie Fako | 2019-01-01 |
| 10085977 | Procaspase 3 activation by combination therapy | Rachel C. Botham, Timothy M. Fan, Mark J. GILBERT, Michael K. Handley, Howard S. Roth +1 more | 2018-10-02 |
| 10085978 | Procaspase combination therapy for glioblastoma | Rachel C. Botham, Timothy M. Fan, Mark J. GILBERT, Michael K. Handley, Avadhut Joshi +2 more | 2018-10-02 |
| 10081592 | Complex and structurally diverse compounds | Robert W. Huigens, III, Karen Morrison, Robert W. Hicklin, II, Timothy A. Flood, Jr. | 2018-09-25 |
| 10022371 | Procaspase-activating compounds and methods | — | 2018-07-17 |
| 9962383 | Compounds, compositions and methods of agelastatin alkaloids | Mohammad Movassaghi | 2018-05-08 |
| 9925180 | Compounds and anti-tumor NQO1 substrates | David Boothman, Joseph S. Bair, Rahul Palchaudhuri, Elizabeth I. Parkinson | 2018-03-27 |
| 9920069 | Compounds for treatment of fluoroquinolone-resistant bacteria | Elizabeth I. Parkinson, Joseph S. Bair | 2018-03-20 |
| 9682060 | Small molecules that induce intrinsic pathway apoptosis | Karson S. Putt, Rahul Palchaudhuri | 2017-06-20 |
| 9663482 | Substituted piperazinyl acetohydrazide procaspase-activating compounds | Howard S. Roth | 2017-05-30 |
| 9643960 | Procaspase activating compounds | Quinn P. Peterson, Danny Chung Hsu, Diana C. West, Timothy M. Fan, Chris J. Novotny | 2017-05-09 |
| 9611266 | Compounds and anti-tumor NQO1 substrates | David Boothman, Joseph S. Bair, Rahul Palchaudhuri, Elizabeth I. Parkinson | 2017-04-04 |
| 9592229 | Potent anticancer activity via dual compound activation | Rachel C. Botham, Timothy M. Fan, Mark J. GILBERT, Michael K. Handley, Theodore M. Tarasow | 2017-03-14 |
| 9522901 | Compositions and methods including cell death inducers and procaspase activation | Karson S. Putt, Quinn P. Peterson, Valerie Fako | 2016-12-20 |
| 9434736 | Compounds, compositions and methods of agelastatin alkaloids | Mohammad Movassaghi | 2016-09-06 |
| 9421202 | Procaspase combination therapy for glioblastoma | Rachel C. Botham, Timothy M. Fan, Mark J. GILBERT, Michael J. Handley, Avadhut Joshi +2 more | 2016-08-23 |
| 9399035 | Procaspase 3 activation by combination therapy | Rachel C. Botham, Timothy M. Fan, Mark J. GILBERT, Michael K. Handley, Howard S. Roth +1 more | 2016-07-26 |
| 9382215 | Therapeutic methods and agents for treating myotonic dystrophy | Steven C. Zimmerman, Chun-Ho Wong, Jessie Peh | 2016-07-05 |
| 9353150 | Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment | Mohammad Movassaghi, Justin Kim, Karen Morrison, Nicolas Cedric Boyer | 2016-05-31 |
| 9249116 | Enzyme-activating compounds and compositions | Howard S. Roth | 2016-02-02 |